Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Quest Patent Research Corporation -- Ignore unavailable to you. Want to Upgrade?

To: RKroupa who wrote (27)	5/23/1999 7:46:00 PM
From: Tommy Hicks	Read Replies (1) \| Respond to of 267

The following is part of the FTC ruling concerning PhaseOut. Pay particular attention to item #2. Has the company obtained some competent and reliable scientific evidence that the product is effective in helping smokers quit the habit? IT IS FURTHER ORDERED that respondents, directly or through any corporation, subsidiary, division or other device, in connection with the manufacturing, labeling, advertising, promotion, offering for sale, sale, or distribution of any smoking-cessation product or cigarette- modification product in or affecting commerce, shall not make any representation, in any manner, expressly or by implication, that: 1. The product reduces the amount of nicotine, tar, carbon monoxide, or any other component of cigarette smoke that smokers get from smoking a cigarette; 2. The product is effective in enabling or helping smokers to quit smoking; 3. The product reduces the risk of smoking-related health problems, including, but not limited to, lung cancer or heart disease, for smokers who continue to smoke; 4. The product reduces the amount of nicotine, tar, carbon monoxide, or any other component of cigarette smoke that smokers get without changing a cigarette's taste or draw; 5. Smokers using the product will not compensate for the product's effects by increasing the number of cigarettes they smoke per day; 6. The product is effective in enabling or helping smokers to quit smoking without withdrawal symptoms; or 7. The product provides immediate health benefits, including, but not limited to, reduced congestion, coughing or windedness, for smokers who continue to smoke; unless, at the time it is made, respondents possess and rely upon competent and reliable scientific evidence that substantiates the representation. th